Marco Clementino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marco Clementino has a total of 209 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Havt
Departamento de Fisiologia e Farmacologia, Universidade Federal do Ceará, Fortaleza, Brazil
10 shared publications - Aldo Angelo Moreira Lima
Universidade Federal do Ceará, Brasil; Universidade Federal do Ceará, Brasil
9 shared publications - Rafhaella Nogueira Della Guardia Gondim
Universidade Federal do Ceará, Brasil
6 shared publications - Armênio Aguiar dos Santos
Universidade Federal do Ceará, Brasil; Universidade Federal do Ceará, Brasil
5 shared publications - José Quirino da Silva-Filho
Center of Biomedicine and Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil
5 shared publications Alexandre Havt
University Federal of Ceará (UFC)
4 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Springer Nature in Research Square
Comparative Genomics of Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter Baumannii Clinical Isolates from an Intensive Care Unit in Northeastern Brazil
Acinetobacter baumannii is an opportunistic pathogen linked to healthcare-associated infections and the dissemination of multidrug-resistant phenotypes in critical hospital settings. In this study, we performed a comparative genomic analysis of clinical isolates identified as A. baumannii by routine hospital microbiology, obtained from an intensive care unit in Northeastern Brazil and classified as susceptible (SEN), multidrug-resistant (MDR), or extensively drug-resistant (XDR). Fifteen isolates were subjected to whole-genome sequencing; after quality control, 14 genomes were included in the main comparative analyses. Genome assembly metrics, functional composition, pangenome, resistome, virulome, Pasteur MLST, core-genome phylogeny, phenotype–genotype concordance, and FastANI-based taxonomic refinement were evaluated. MDR and XDR isolates carried a higher burden of antimicrobial resistance (AMR) genes than SEN isolates. Pangenome analysis revealed a conserved core genome combined with variable accessory content, whereas the virulome was relatively conserved across phenotypic groups. Quinolone resistance-determining region (QRDR) mutations in gyrA and/or parC were detected in ciprofloxacin-resistant isolates, supporting the role of chromosomal mechanisms in fluoroquinolone resistance that may not be captured by analyses restricted to acquired resistance genes. FastANI analysis further revealed taxonomic discrepancies in two susceptible isolates, highlighting the complementary value of WGS for hospital surveillance and taxonomic refinement within the Acinetobacter calcoaceticus–baumannii complex. Overall, our findings indicate that antimicrobial resistance in these clinical isolates is a multifactorial phenomenon shaped by clonal diversity, accessory genome variation, AMR gene burden, chromosomal resistance mechanisms, and taxonomic complexity within the ACB complex.
- 26 October 2026
- Published by Springer Nature in Research Square
Open AccessComparative Genomics of Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter Baumannii Clinical Isolates from an Intensive Care Unit in Northeastern Brazil
Acinetobacter baumannii is an opportunistic pathogen linked to healthcare-associated infections and the dissemination of multidrug-resistant phenotypes in critical hospital settings. In this study, we performed a comparative genomic analysis of clinical isolates identified as A. baumannii by routine hospital microbiology, obtained from an intensive care unit in Northeastern Brazil and classified as susceptible (SEN), multidrug-resistant (MDR), or extensively drug-resistant (XDR). Fifteen isolates were subjected to whole-genome sequencing; after quality control, 14 genomes were included in the main comparative analyses. Genome assembly metrics, functional composition, pangenome, resistome, virulome, Pasteur MLST, core-genome phylogeny, phenotype–genotype concordance, and FastANI-based taxonomic refinement were evaluated. MDR and XDR isolates carried a higher burden of antimicrobial resistance (AMR) genes than SEN isolates. Pangenome analysis revealed a conserved core genome combined with variable accessory content, whereas the virulome was relatively conserved across phenotypic groups. Quinolone resistance-determining region (QRDR) mutations in gyrA and/or parC were detected in ciprofloxacin-resistant isolates, supporting the role of chromosomal mechanisms in fluoroquinolone resistance that may not be captured by analyses restricted to acquired resistance genes. FastANI analysis further revealed taxonomic discrepancies in two susceptible isolates, highlighting the complementary value of WGS for hospital surveillance and taxonomic refinement within the Acinetobacter calcoaceticus–baumannii complex. Overall, our findings indicate that antimicrobial resistance in these clinical isolates is a multifactorial phenomenon shaped by clonal diversity, accessory genome variation, AMR gene burden, chromosomal resistance mechanisms, and taxonomic complexity within the ACB complex.
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Systems-Level Resistome and Proteomic Remodeling Underlying Multidrug and Extensively Drug-ResistantGram-Negative Pathogens in an Intensive Care Unit
Antimicrobial resistance compromises therapeutic efficacy and represents a serious global health problem. This study characterized the phenotype, genome, and quantitative proteomic profile of Gram-negative bacteria isolated from an intensive care unit (ICU) in Northeastern Brazil. After ethical approval, 259 isolates of Gram-negative bacteria were collected between 2019 and 2021. The samples underwent standard microbiological procedures, antimicrobial susceptibility testing, and molecular detection of resistance genes by qPCR. Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa isolates classified as susceptible, MDR, and XDR were selected for whole-genome sequencing and label-free quantitative proteomics. High resistance rates were observed, exceeding 60% for penicillins and cephalosporins, and ≥44%, 93%, and 61% for carbapenems in K. pneumoniae, A. baumannii, and P. aeruginosa, respectively. The ESBL phenotype occurred in more than 46% of isolates, with high resistance also to aminoglycosides and fluoroquinolones. MDR and XDR phenotypes were identified in more than 30% of the strains. Genomic analyses revealed dense resistomes, with widespread coexistence of β-lactamases (bla_KPC, bla_NDM, bla_CTX-M, and OXA) and RND-type (MEXs) and acrAB-tolC efflux pump systems. The complexity of the resistome increased from susceptible to MDR/XDR isolates, with no loss of virulence genes. Proteomics revealed enrichment of β-lactamases, efflux components, outer membrane proteins, oxidative stress defense mechanisms, iron acquisition, and global regulators. XDR isolates showed envelope remodeling, proteostasis activation, and metabolic adaptation. The findings demonstrate a high prevalence of antimicrobial resistance, sustained by an integrated system involving enzymatic inactivation, efflux, membrane remodeling, and regulatory reprogramming, highlighting the complexity of resistance in critical ICU pathogens.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessSystems-Level Resistome and Proteomic Remodeling Underlying Multidrug and Extensively Drug-ResistantGram-Negative Pathogens in an Intensive Care Unit
Antimicrobial resistance compromises therapeutic efficacy and represents a serious global health problem. This study characterized the phenotype, genome, and quantitative proteomic profile of Gram-negative bacteria isolated from an intensive care unit (ICU) in Northeastern Brazil. After ethical approval, 259 isolates of Gram-negative bacteria were collected between 2019 and 2021. The samples underwent standard microbiological procedures, antimicrobial susceptibility testing, and molecular detection of resistance genes by qPCR. Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa isolates classified as susceptible, MDR, and XDR were selected for whole-genome sequencing and label-free quantitative proteomics. High resistance rates were observed, exceeding 60% for penicillins and cephalosporins, and ≥44%, 93%, and 61% for carbapenems in K. pneumoniae, A. baumannii, and P. aeruginosa, respectively. The ESBL phenotype occurred in more than 46% of isolates, with high resistance also to aminoglycosides and fluoroquinolones. MDR and XDR phenotypes were identified in more than 30% of the strains. Genomic analyses revealed dense resistomes, with widespread coexistence of β-lactamases (bla_KPC, bla_NDM, bla_CTX-M, and OXA) and RND-type (MEXs) and acrAB-tolC efflux pump systems. The complexity of the resistome increased from susceptible to MDR/XDR isolates, with no loss of virulence genes. Proteomics revealed enrichment of β-lactamases, efflux components, outer membrane proteins, oxidative stress defense mechanisms, iron acquisition, and global regulators. XDR isolates showed envelope remodeling, proteostasis activation, and metabolic adaptation. The findings demonstrate a high prevalence of antimicrobial resistance, sustained by an integrated system involving enzymatic inactivation, efflux, membrane remodeling, and regulatory reprogramming, highlighting the complexity of resistance in critical ICU pathogens.
- Open Access
- 1 June 2026
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 330 (6) , G718-G726
The protease inhibitor darunavir prevents esophagitis and impairments in esophageal barrier function in a mouse model of GERD
The gastroesophageal reflux of pepsin contributes importantly to esophageal damage in patients with GERD. We have found that darunavir, a drug presently used to treat HIV, inhibits pepsin activity and, in an animal model of GERD, darunavir reduces esophageal inflammation and HIF-2α levels while preserving levels of tight junction proteins and esophageal mucosal integrity. These findings suggest that darunavir might have a role as a novel treatment for GERD.
- 1 June 2026
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 330 (6) , G718-G726
Open AccessThe protease inhibitor darunavir prevents esophagitis and impairments in esophageal barrier function in a mouse model of GERD
The gastroesophageal reflux of pepsin contributes importantly to esophageal damage in patients with GERD. We have found that darunavir, a drug presently used to treat HIV, inhibits pepsin activity and, in an animal model of GERD, darunavir reduces esophageal inflammation and HIF-2α levels while preserving levels of tight junction proteins and esophageal mucosal integrity. These findings suggest that darunavir might have a role as a novel treatment for GERD.
- Open Access
- 29 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1)
Insights of β ‐Lactams Resistance in Klebsiella pneumoniae Clinical Isolates: A Focus on Molecular Identification of Drug Resistance
Klebsiella pneumoniae is associated with high antimicrobial resistance and is commonly isolated from colonization and healthcare‐associated infections (HAIs). This study is aimed at developing and validating molecular assays to detect resistance genes belonging to the bla family in resistant K. pneumoniae isolates. The genes included belong to the subfamilies: bla SHV , bla TEM , bla NDM , bla KPC , bla GES , bla CTX‐M, and relevant variants of the bla OXA subfamily. The identified genotypic profile showed a high prevalence of genes belonging to Ambler′s classes of beta‐lactamases A, B, and D, which was in accordance with the phenotypic results obtained for the isolates investigated. A high prevalence of resistance to penicillins, cephalosporins, and carbapenems was observed. In conclusion, the assays developed were efficient in detecting the main resistance genes of the bla family in K. pneumoniae , revealing a concerning regional burden of resistance genes.
- 29 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1)
Open AccessInsights of β ‐Lactams Resistance in Klebsiella pneumoniae Clinical Isolates: A Focus on Molecular Identification of Drug Resistance
Klebsiella pneumoniae is associated with high antimicrobial resistance and is commonly isolated from colonization and healthcare‐associated infections (HAIs). This study is aimed at developing and validating molecular assays to detect resistance genes belonging to the bla family in resistant K. pneumoniae isolates. The genes included belong to the subfamilies: bla SHV , bla TEM , bla NDM , bla KPC , bla GES , bla CTX‐M, and relevant variants of the bla OXA subfamily. The identified genotypic profile showed a high prevalence of genes belonging to Ambler′s classes of beta‐lactamases A, B, and D, which was in accordance with the phenotypic results obtained for the isolates investigated. A high prevalence of resistance to penicillins, cephalosporins, and carbapenems was observed. In conclusion, the assays developed were efficient in detecting the main resistance genes of the bla family in K. pneumoniae , revealing a concerning regional burden of resistance genes.
- Open Access
- 31 October 2025
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 23 (4) , 502-511
Restoration of colonic barrier function by tofacitinib in experimental colitis: anti-inflammatory effects and decreased expression of claudins-2 and claudin-15
Background/Aims: Inflammatory bowel disease can be triggered by disturbances in intestinal mucosal integrity, leading to bacterial transmigration. The treatment of inflammatory bowel diseases must not only aim to reduce inflammation, but also to reverse the damage to mucosal barrier function. Janus kinase (JAK) inhibitors have been used to treat inflammatory diseases, including ulcerative colitis. However, little is known about the ability of this class of drugs to reverse the loss of mucosal integrity. This study evaluated the effects of tofacitinib, a JAK pathway inhibitor, on inflammation and colonic mucosal integrity in a rat model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis. Methods: Colitis was induced in Wistar rats via rectal administration of TNBS (20 mg+50% ethanol). The control group received only saline. The animals were pretreated with tofacitinib (15 mg/kg) or saline 30 minutes before induction and twice daily thereafter. Seven days after induction, the animals were euthanized, the colon was removed, and myeloperoxidase activity, baseline transepithelial electrical resistance (TER), TER after 1 hour, and fluorescein permeability were assessed. Tight junction proteins in the colon (claudin-2, claudin-15, and tricellulin) were detected using Western blotting. Results: Tofacitinib treatment significantly reduced (P< 0.05) the inflammatory parameters and preserved the integrity of the intestinal epithelial barrier compared with the colitis group (P< 0.05), increased baseline TER, reduced the drop in TER after 1 hour, and decreased paracellular permeability to fluorescein by reducing claudin-2 and claudin-15 expression. Conclusions: JAK inhibition by tofacitinib restored colonic barrier function through antiinflammatory effects and decreased claudin-2 and claudin-15 expressions.
- 31 October 2025
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 23 (4) , 502-511
Open AccessRestoration of colonic barrier function by tofacitinib in experimental colitis: anti-inflammatory effects and decreased expression of claudins-2 and claudin-15
Background/Aims: Inflammatory bowel disease can be triggered by disturbances in intestinal mucosal integrity, leading to bacterial transmigration. The treatment of inflammatory bowel diseases must not only aim to reduce inflammation, but also to reverse the damage to mucosal barrier function. Janus kinase (JAK) inhibitors have been used to treat inflammatory diseases, including ulcerative colitis. However, little is known about the ability of this class of drugs to reverse the loss of mucosal integrity. This study evaluated the effects of tofacitinib, a JAK pathway inhibitor, on inflammation and colonic mucosal integrity in a rat model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis. Methods: Colitis was induced in Wistar rats via rectal administration of TNBS (20 mg+50% ethanol). The control group received only saline. The animals were pretreated with tofacitinib (15 mg/kg) or saline 30 minutes before induction and twice daily thereafter. Seven days after induction, the animals were euthanized, the colon was removed, and myeloperoxidase activity, baseline transepithelial electrical resistance (TER), TER after 1 hour, and fluorescein permeability were assessed. Tight junction proteins in the colon (claudin-2, claudin-15, and tricellulin) were detected using Western blotting. Results: Tofacitinib treatment significantly reduced (P< 0.05) the inflammatory parameters and preserved the integrity of the intestinal epithelial barrier compared with the colitis group (P< 0.05), increased baseline TER, reduced the drop in TER after 1 hour, and decreased paracellular permeability to fluorescein by reducing claudin-2 and claudin-15 expression. Conclusions: JAK inhibition by tofacitinib restored colonic barrier function through antiinflammatory effects and decreased claudin-2 and claudin-15 expressions.
- Open Access
- 13 May 2025
- Published by Wiley
Transcriptomic Remodeling and Survival Strategies of Extensively Drug-Resistant Klebsiella pneumoniae Under Meropenem Pressure
Klebsiella pneumoniae is an opportunistic pathogen of great medical relevance due to its high virulence and resistance to antimicrobials. Carbapenem resistance is mediated by carbapenemases and represents a global clinical challenge due to the limited therapeutic arsenal. Transcriptomic assays can elucidate antimicrobial resistance mechanisms and enables the identification of pharmacological targets in extensively drug-resistant (XDR) Klebsiella pneumoniae . This study evaluated the transcriptomic profile of carbapenemase-producing K. pneumoniae after exposure to meropenem and assessed its morpho-functional and metabolic pathway modifications in response to antibiotic treatment. The sensitivity of carbapenemase-producing K. pneumoniae, isolated from the ICU of the University Hospital Walter Cantídio in Fortaleza, CE, was determined by disk diffusion, broth microdilution, and the automated VITEK-2® method. The strain was exposed to subinhibitory concentrations of meropenem and their bacterial growth curve was determined. Total RNA was extracted from bacteria with and without antibiotic treatment at their growth curve log phase. RNA sequencing (RNA-Seq) was performed on a high-throughput MiSeq platform, and differential expression analysis identified both upregulated and downregulated transcripts. Following exposure to meropenem, K. pneumoniae showed increased expression of genes related to the plasma membrane, efflux pumps, and cell wall modifications, as well as genes involved in resistance to polymyxins and changes in energy metabolism, such as glycolysis and fermentation. Furthermore, genes associated with antioxidant systems and oxidative stress response were expressed at elevated levels, indicating a survival mechanism under selective pressure. On the other hand, transcripts associated with protein metabolism and DNA synthesis were downregulated, suggesting a global metabolic reprogramming aimed at cell maintenance under hostile conditions. Thus, exposure to meropenem induced complex adaptations in K. pneumoniae . The results provide valuable insights into the resistance and adaptation mechanisms of this bacterium, highlighting potential targets for new therapeutic strategies.
- 13 May 2025
- Published by Wiley
Open AccessTranscriptomic Remodeling and Survival Strategies of Extensively Drug-Resistant Klebsiella pneumoniae Under Meropenem Pressure
Klebsiella pneumoniae is an opportunistic pathogen of great medical relevance due to its high virulence and resistance to antimicrobials. Carbapenem resistance is mediated by carbapenemases and represents a global clinical challenge due to the limited therapeutic arsenal. Transcriptomic assays can elucidate antimicrobial resistance mechanisms and enables the identification of pharmacological targets in extensively drug-resistant (XDR) Klebsiella pneumoniae . This study evaluated the transcriptomic profile of carbapenemase-producing K. pneumoniae after exposure to meropenem and assessed its morpho-functional and metabolic pathway modifications in response to antibiotic treatment. The sensitivity of carbapenemase-producing K. pneumoniae, isolated from the ICU of the University Hospital Walter Cantídio in Fortaleza, CE, was determined by disk diffusion, broth microdilution, and the automated VITEK-2® method. The strain was exposed to subinhibitory concentrations of meropenem and their bacterial growth curve was determined. Total RNA was extracted from bacteria with and without antibiotic treatment at their growth curve log phase. RNA sequencing (RNA-Seq) was performed on a high-throughput MiSeq platform, and differential expression analysis identified both upregulated and downregulated transcripts. Following exposure to meropenem, K. pneumoniae showed increased expression of genes related to the plasma membrane, efflux pumps, and cell wall modifications, as well as genes involved in resistance to polymyxins and changes in energy metabolism, such as glycolysis and fermentation. Furthermore, genes associated with antioxidant systems and oxidative stress response were expressed at elevated levels, indicating a survival mechanism under selective pressure. On the other hand, transcripts associated with protein metabolism and DNA synthesis were downregulated, suggesting a global metabolic reprogramming aimed at cell maintenance under hostile conditions. Thus, exposure to meropenem induced complex adaptations in K. pneumoniae . The results provide valuable insights into the resistance and adaptation mechanisms of this bacterium, highlighting potential targets for new therapeutic strategies.
- Open Access
- 8 May 2025
- Published by Wiley
Lytic bacteriophages isolated from Porangabussu’s lagoon in Fortaleza, Ceará target MDR Klebsiella pneumoniae
The rise of bacterial resistance is one of contemporary public health’s greatest challenges, driven by multidrug-resistant (MDR) pathogens. Developing effective, cost-efficient therapies to combat such infections is critical. Klebsiella pneumoniae , a gram-negative opportunistic bacterium, causes severe conditions like pneumonia, septicemia, and urinary infections. Bacteriophage therapy, an approach using viruses to target bacteria, is re-emerging as a promising alternative. This study aimed to isolate and characterize lytic bacteriophages with therapeutic potential against antibiotic-resistant K . pneumoniae strains. A water sample from the Porangabussu lagoon underwent chloroform treatment, centrifugation, and filtration. The spot test technique confirmed the presence of bacteriophages, and nucleic acid was extracted. Bioinformatic analysis identified target genes for the identification of K. pneumoniae phages leading to the design of specific primers: cap, and ack. qPCR analyses revealed bacteriophages with therapeutic potential in the water sample. These findings offer promising perspectives for combating MDR K. pneumoniae infections.
- 8 May 2025
- Published by Wiley
Open AccessLytic bacteriophages isolated from Porangabussu’s lagoon in Fortaleza, Ceará target MDR Klebsiella pneumoniae
The rise of bacterial resistance is one of contemporary public health’s greatest challenges, driven by multidrug-resistant (MDR) pathogens. Developing effective, cost-efficient therapies to combat such infections is critical. Klebsiella pneumoniae , a gram-negative opportunistic bacterium, causes severe conditions like pneumonia, septicemia, and urinary infections. Bacteriophage therapy, an approach using viruses to target bacteria, is re-emerging as a promising alternative. This study aimed to isolate and characterize lytic bacteriophages with therapeutic potential against antibiotic-resistant K . pneumoniae strains. A water sample from the Porangabussu lagoon underwent chloroform treatment, centrifugation, and filtration. The spot test technique confirmed the presence of bacteriophages, and nucleic acid was extracted. Bioinformatic analysis identified target genes for the identification of K. pneumoniae phages leading to the design of specific primers: cap, and ack. qPCR analyses revealed bacteriophages with therapeutic potential in the water sample. These findings offer promising perspectives for combating MDR K. pneumoniae infections.
- Open Access
- 5 May 2025
- Published by Wiley
Transcriptomic Remodeling and Survival Strategies of Extensively Drug-Resistant Klebsiella pneumoniae Under Meropenem Pressure
Klebsiella pneumoniae is an opportunistic pathogen of great medical relevance due to its high virulence and resistance to antimicrobials. Carbapenem resistance is mediated by carbapenemases and represents a global clinical challenge due to the limited therapeutic arsenal. Transcriptomic assays can elucidate antimicrobial resistance mechanisms and enables the identification of pharmacological targets in extensively drug-resistant (XDR) Klebsiella pneumoniae . This study evaluated the transcriptomic profile of carbapenemase-producing K. pneumoniae after exposure to meropenem and assessed its morpho-functional and metabolic pathway modifications in response to antibiotic treatment. The sensitivity of carbapenemase-producing K. pneumoniae, isolated from the ICU of the University Hospital Walter Cantídio in Fortaleza, CE, was determined by disk diffusion, broth microdilution, and the automated VITEK-2® method. The strain was exposed to subinhibitory concentrations of meropenem and their bacterial growth curve was determined. Total RNA was extracted from bacteria with and without antibiotic treatment at their growth curve log phase. RNA sequencing (RNA-Seq) was performed on a high-throughput MiSeq platform, and differential expression analysis identified both upregulated and downregulated transcripts. Following exposure to meropenem, K. pneumoniae showed increased expression of genes related to the plasma membrane, efflux pumps, and cell wall modifications, as well as genes involved in resistance to polymyxins and changes in energy metabolism, such as glycolysis and fermentation. Furthermore, genes associated with antioxidant systems and oxidative stress response were expressed at elevated levels, indicating a survival mechanism under selective pressure. On the other hand, transcripts associated with protein metabolism and DNA synthesis were downregulated, suggesting a global metabolic reprogramming aimed at cell maintenance under hostile conditions. Thus, exposure to meropenem induced complex adaptations in K. pneumoniae . The results provide valuable insights into the resistance and adaptation mechanisms of this bacterium, highlighting potential targets for new therapeutic strategies.
- 5 May 2025
- Published by Wiley
Open AccessTranscriptomic Remodeling and Survival Strategies of Extensively Drug-Resistant Klebsiella pneumoniae Under Meropenem Pressure
Klebsiella pneumoniae is an opportunistic pathogen of great medical relevance due to its high virulence and resistance to antimicrobials. Carbapenem resistance is mediated by carbapenemases and represents a global clinical challenge due to the limited therapeutic arsenal. Transcriptomic assays can elucidate antimicrobial resistance mechanisms and enables the identification of pharmacological targets in extensively drug-resistant (XDR) Klebsiella pneumoniae . This study evaluated the transcriptomic profile of carbapenemase-producing K. pneumoniae after exposure to meropenem and assessed its morpho-functional and metabolic pathway modifications in response to antibiotic treatment. The sensitivity of carbapenemase-producing K. pneumoniae, isolated from the ICU of the University Hospital Walter Cantídio in Fortaleza, CE, was determined by disk diffusion, broth microdilution, and the automated VITEK-2® method. The strain was exposed to subinhibitory concentrations of meropenem and their bacterial growth curve was determined. Total RNA was extracted from bacteria with and without antibiotic treatment at their growth curve log phase. RNA sequencing (RNA-Seq) was performed on a high-throughput MiSeq platform, and differential expression analysis identified both upregulated and downregulated transcripts. Following exposure to meropenem, K. pneumoniae showed increased expression of genes related to the plasma membrane, efflux pumps, and cell wall modifications, as well as genes involved in resistance to polymyxins and changes in energy metabolism, such as glycolysis and fermentation. Furthermore, genes associated with antioxidant systems and oxidative stress response were expressed at elevated levels, indicating a survival mechanism under selective pressure. On the other hand, transcripts associated with protein metabolism and DNA synthesis were downregulated, suggesting a global metabolic reprogramming aimed at cell maintenance under hostile conditions. Thus, exposure to meropenem induced complex adaptations in K. pneumoniae . The results provide valuable insights into the resistance and adaptation mechanisms of this bacterium, highlighting potential targets for new therapeutic strategies.
- 2 May 2025
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 70 (8) , 2674-2683
Impairment of Esophageal Barrier Integrity: New Insights into Esophageal Symptoms in Post-COVID-19
Background The COVID-19 pandemic, caused by SARS-CoV-2, has unveiled a range of symptoms beyond the respiratory system, including significant gastrointestinal manifestations. Aims This study explores the prevalence and intensity of gastroesophageal symptoms in post-COVID-19 patients and the integrity of the esophageal epithelial barrier. Methods We conducted a prospective longitudinal cohort study with 55 patients hospitalized due to COVID-19 at a University Hospital. Patients were evaluated during hospitalization and between 3 and 6 months post-discharge, using validated questionnaires for gastrointestinal and gastroesophageal reflux symptoms. Additionally, 25 of these patients underwent upper digestive endoscopy, with esophageal mucosal biopsies analyzed for transepithelial electrical resistance (TER), permeability, and expression of inflammatory cytokines and cell junction proteins. Data expressed as mean EPM, inference by two-way ANOVA. Results Results were considered statistically significant at p < 0.05. There were significant increases in heartburn and acid reflux symptoms in post-COVID-19 patients, as measured by the GSRS questionnaire. Biopsies from post-COVID patients revealed increased esophageal permeability when compared to non-COVID patients in acidic media (pH 2: non-COVID-19: 717.8 ± 168.2 vs. post-COVID-19: 1377.6 ± 316.4), suggesting compromised mucosal barrier. Furthermore, IL-8 levels and expression of Claudin-2 were elevated in these patients. Conclusions The data suggested that COVID-19 infection may cause lasting damage to the esophageal epithelial barrier, increasing its permeability and provoking an exacerbated inflammatory response. These changes may explain the prevalence of post-infection gastroesophageal symptoms. Our findings underscored the importance of continuous monitoring and the development of therapeutic strategies to mitigate gastroesophageal effects in patients recovering from COVID-19. Graphical Abstract
- 2 May 2025
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 70 (8) , 2674-2683
Impairment of Esophageal Barrier Integrity: New Insights into Esophageal Symptoms in Post-COVID-19
Background The COVID-19 pandemic, caused by SARS-CoV-2, has unveiled a range of symptoms beyond the respiratory system, including significant gastrointestinal manifestations. Aims This study explores the prevalence and intensity of gastroesophageal symptoms in post-COVID-19 patients and the integrity of the esophageal epithelial barrier. Methods We conducted a prospective longitudinal cohort study with 55 patients hospitalized due to COVID-19 at a University Hospital. Patients were evaluated during hospitalization and between 3 and 6 months post-discharge, using validated questionnaires for gastrointestinal and gastroesophageal reflux symptoms. Additionally, 25 of these patients underwent upper digestive endoscopy, with esophageal mucosal biopsies analyzed for transepithelial electrical resistance (TER), permeability, and expression of inflammatory cytokines and cell junction proteins. Data expressed as mean EPM, inference by two-way ANOVA. Results Results were considered statistically significant at p < 0.05. There were significant increases in heartburn and acid reflux symptoms in post-COVID-19 patients, as measured by the GSRS questionnaire. Biopsies from post-COVID patients revealed increased esophageal permeability when compared to non-COVID patients in acidic media (pH 2: non-COVID-19: 717.8 ± 168.2 vs. post-COVID-19: 1377.6 ± 316.4), suggesting compromised mucosal barrier. Furthermore, IL-8 levels and expression of Claudin-2 were elevated in these patients. Conclusions The data suggested that COVID-19 infection may cause lasting damage to the esophageal epithelial barrier, increasing its permeability and provoking an exacerbated inflammatory response. These changes may explain the prevalence of post-infection gastroesophageal symptoms. Our findings underscored the importance of continuous monitoring and the development of therapeutic strategies to mitigate gastroesophageal effects in patients recovering from COVID-19. Graphical Abstract
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e03172025
Cytokine Profile in Women Affected by Chikungunya: Analysis of a Prospective Cohort in Northeastern Brazil
Background: Chikungunya (CHIK) is an acute febrile arthritic illness caused by Aedes aegypti and Aedes albopictus mosquitoes. Understanding the pathophysiology of CHIK is crucial because of the wide distribution of cases and the lack of specific treatments or validated biomarkers. This study aimed to describe the cytokine profiles of female patients with laboratory-confirmed CHIK across the three clinical phases of the disease, monitored at an outpatient clinic in Northeastern Brazil. Additionally, this study evaluated whether cytokine levels were associated with persistent arthralgia and the presence of comorbidities. Methods: This was a prospective cohort study conducted from 2021 to 2024, including 40 female patients and 10 heathy controls (women aged ≥18 years, without comorbidities, not taking medications and non-reactive serologies for CHIK). Blood samples were collected at five time points (0, 21, 90, 180, and 360 days after the symptom onset). Results: More than half of the patients reported persistent pain. Among CHIK-infected women, interleukin (IL)-10 levels remained elevated from day 21, with statistically significant differences between D0 and D180 and D0 and D360 (p = 0.027). IL-18 levels increased significantly between D0 and D21 (p = 0.020). Conclusions: Dynamic cytokine behavior throughout the CHIK phase has been described in other studies and may be influenced by host immunogenetics and other factors.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e03172025
Open AccessCytokine Profile in Women Affected by Chikungunya: Analysis of a Prospective Cohort in Northeastern Brazil
Background: Chikungunya (CHIK) is an acute febrile arthritic illness caused by Aedes aegypti and Aedes albopictus mosquitoes. Understanding the pathophysiology of CHIK is crucial because of the wide distribution of cases and the lack of specific treatments or validated biomarkers. This study aimed to describe the cytokine profiles of female patients with laboratory-confirmed CHIK across the three clinical phases of the disease, monitored at an outpatient clinic in Northeastern Brazil. Additionally, this study evaluated whether cytokine levels were associated with persistent arthralgia and the presence of comorbidities. Methods: This was a prospective cohort study conducted from 2021 to 2024, including 40 female patients and 10 heathy controls (women aged ≥18 years, without comorbidities, not taking medications and non-reactive serologies for CHIK). Blood samples were collected at five time points (0, 21, 90, 180, and 360 days after the symptom onset). Results: More than half of the patients reported persistent pain. Among CHIK-infected women, interleukin (IL)-10 levels remained elevated from day 21, with statistically significant differences between D0 and D180 and D0 and D360 (p = 0.027). IL-18 levels increased significantly between D0 and D21 (p = 0.020). Conclusions: Dynamic cytokine behavior throughout the CHIK phase has been described in other studies and may be influenced by host immunogenetics and other factors.